None

None

subjects showing signs of acute respiratory distress syndrome (ards) or respiratory failure necessitating mechanical ventilation at the time of screening history of severe chronic respiratory disease and requirement for long-term oxygen therapy subjects showing signs of clinical jaundice at the time of screening. history of moderate and severe liver disease (child-pugh score >12) subjects requiring renal replacement therapy (rrt) at the time of screening history of uncontrolled diabetes history of severe chronic kidney disease or requiring dialysis any uncontrolled active systemic infection requiring admission to an intensive care unit (icu); note: subjects infected with chronic hepatitis b virus or hepatitis c virus will be eligible for the study if they have no signs of hepatic decompensation. patients with malignant tumor, or other serious systemic diseases patients who are participating in other clinical trials patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to viusid or asbrip are not eligible; and inability to provide informed consent or to comply with test requirements

subjects showing signs of acute respiratory distress syndrome (ards) or respiratory failure necessitating mechanical ventilation at the time of screening history of severe chronic respiratory disease and requirement for long-term oxygen therapy subjects showing signs of clinical jaundice at the time of screening. history of moderate and severe liver disease (child-pugh score >12) subjects requiring renal replacement therapy (rrt) at the time of screening history of uncontrolled diabetes history of severe chronic kidney disease or requiring dialysis any uncontrolled active systemic infection requiring admission to an intensive care unit (icu); note: subjects infected with chronic hepatitis b virus or hepatitis c virus will be eligible for the study if they have no signs of hepatic decompensation. patients with malignant tumor, or other serious systemic diseases patients who are participating in other clinical trials patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to viusid or asbrip are not eligible; and inability to provide informed consent or to comply with test requirements

1. subjects showing signs of acute respiratory distress syndrome (ards) or respiratory failure necessitating mechanical ventilation at the time of screening 2. history of severe chronic respiratory disease and requirement for long-term oxygen therapy 3. subjects showing signs of clinical jaundice at the time of screening. 4. history of moderate and severe liver disease (child-pugh score >12) 5. subjects requiring renal replacement therapy (rrt) at the time of screening 6. history of uncontrolled diabetes 7. history of severe chronic kidney disease or requiring dialysis 8. any uncontrolled active systemic infection requiring admission to an intensive care unit (icu); note: subjects infected with chronic hepatitis b virus or hepatitis c virus will be eligible for the study if they have no signs of hepatic decompensation. 9. patients with malignant tumor, or other serious systemic diseases 10. patients who are participating in other clinical trials 11. patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to viusid or asbrip are not eligible; and 12. inability to provide informed consent or to comply with test requirements

1. subjects showing signs of acute respiratory distress syndrome (ards) or respiratory failure necessitating mechanical ventilation at the time of screening 2. history of severe chronic respiratory disease and requirement for long-term oxygen therapy 3. subjects showing signs of clinical jaundice at the time of screening. 4. history of moderate and severe liver disease (child-pugh score >12) 5. subjects requiring renal replacement therapy (rrt) at the time of screening 6. history of uncontrolled diabetes 7. history of severe chronic kidney disease or requiring dialysis 8. any uncontrolled active systemic infection requiring admission to an intensive care unit (icu); note: subjects infected with chronic hepatitis b virus or hepatitis c virus will be eligible for the study if they have no signs of hepatic decompensation. 9. patients with malignant tumor, or other serious systemic diseases 10. patients who are participating in other clinical trials 11. patients who have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to viusid or asbrip are not eligible; and 12. inability to provide informed consent or to comply with test requirements